Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by smush74on Aug 01, 2013 5:40pm

141 Views

Post# 21645043

RE:RE:RE:RE:Check the graph of brokester bankster manipulation the day before the 2nd quarter earnings report came out

it is how the market works, quit with the bankster crap. Stick with today, if you want to stick with the past then you know that DND took a beating in 08 and 09 and it was selling under 1$ and it also took another beating when they got refused by the FDA years back. Guess what some of us were here long before the hype, and yes even sold some at 5$ for a nice profit. Stop complaining and enjoy the ride until you reach your out position.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!